CFTR inhibition mimics the cystic fibrosis inflammatory profile

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 292, Issue 2, 2007, Pages

  Perez, Aura ^a   Issler, Amanda C ^a   Cotton, Calvin U ^a   Kelley, Thomas J ^a   Verkman, Alan S ^b   Davis, Pamela B ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cystic fibrosis transmembrane conductance regulator; Cytokines; Epithelial sodium channel; Inflammation; Pseudomonas

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMAD3 PROTEIN; SODIUM CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPAN BLUE;

AIRWAY; ARTICLE; CELL STRUCTURE; CILIARY MOTILITY; CYSTIC FIBROSIS; ELECTRON MICROSCOPY; EPITHELIUM CELL; GENETIC DIFFERENCE; HUMAN; HUMAN CELL; MEMBRANE CONDUCTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING;

AMILORIDE; CELL DIFFERENTIATION; CELL NUCLEUS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOKINES; ELECTRIC CONDUCTIVITY; EPITHELIAL CELLS; HUMANS; INFLAMMATION; MOLECULAR MIMICRY; MUTANT PROTEINS; PROTEIN TRANSPORT; RHOA GTP-BINDING PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR RELA;

EID: 33847025695     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00403.2005     Document Type: Article

References (30)

1. Aldallal N, McNaughton EE, Manzel JJ, Richards AM, Zabner J, Ferkol TW, Look DC. Inflammatory response in airway epithelial cells isolated from patients with cystic fibrosis. Am J Respir Crit Care Med 166: 1248-1256, 2002.
2. Becker MN, Sauer MS, Muhlebach MS, Hirsh AJ, Wu Q, Verghese MW, Randell SH. Cytokine secretion by cystic fibrosis airway epithelial cells. Am J Respir Crit Care Med 169: 645-653, 2003.
3. Blackwell TS, Stecenko AA, Christman JW. Dysregulated NF-κB activation in cystic fibrosis: evidence for a primary inflammatory disorder. Am J Physiol Lung Cell Mol Physiol 281: L69-L70, 2001.
4. Bryan R, Kube D, Perez A, Davis PB, Prince A. Overproduction of the CFTR R domain leads to increased levels of asialoGM1 and increased Pseudomonas aeruginosa binding by epithelial cells. Am J Respir Cell Mol Biol 19: 269-277, 1998.
5. Davis PB, Silski C, Kercsmar C, Infeld M. β-Adrenergic receptors in human tracheal epithelial cells in primary culture. Am J Physiol Cell Physiol 258: C71-C76, 1990.
6. DiMango E, Ratner AJ, Bryan R, Tabibi S, Prince A. Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest 101: 2598-2605, 1998.
7. Eidelman O, Srivastava M, Zhang J, Leighton X, Murtie J, Jozwik C. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway. Mol Med 7: 523-534, 2001.
8. Karp PH, Moninger TO, Weber SP, Nesselhauf TS, Launspach JL, Zabner J, Welsh MJ. An in vitro model of differentiated human airway epithelia. Methods for establishing primary cultures. Methods Mol Biol 188: 15-37, 2002.
9. Kelley TJ, Elmer HL, Corey DA. Reduced Smad3 protein expression and altered transforming growth factor-beta1-mediated signaling in cystic fibrosis epithelial cells. Am J Respir Cell Mol Biol 25: 732-738, 2001.
10. Kercsmar CM, Infeld M, Silski C, and Davis PB. Adenosine 3:5 cyclic monophosphate synthesis by human tracheal epithelial cells. Am J Respir Cell Mol Biol 2: 33-39, 1990.
11. Kreiselmeier NE, Kraynack NC, Corey DA, Kelley TJ. Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells. Am J Physiol Lung Cell Mol Physiol 285: L1286-L1295, 2003.
12. Kube D, Adams L, Perez A, Davis PB. Terminal sialylation is altered in airway cells with impaired CFTR-mediated chloride transport. Am J Physiol Lung Cell Mol Physiol 280: L482-L492, 2001.
13. Kube D, Sontich U, Fletcher D, Davis PB. Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines. Am J Physiol Lung Cell Mol Physiol 280: L493-L502, 2001.
14. Ma T, Thiagarajah JR, Yang H, Sonawane N, Folli C, Galietta LJV, Verkman AS. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera-toxin induced intestinal fluid secretion. J Clin Invest 110: 1651-1658, 2002.
15. + absorption produces cystic fibrosis-like lung disease in mice. Nat Med 10: 487-493, 2004.
16. Matsui H, Grubb BR, Tarran R, Randell SH, Gatzy JT, Davis CW, Boucher RC. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95: 1005-1015, 1998.
17. Muanprasat C, Sonawane ND, Salinas D, Taddei A, Galietta LJ, Verkman AS. Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy. J Gen Physiol 124: 125-137, 2004.
18. Pedemonte N, Lukacs GL, Du K, Caci E, Zegarra-Moran O, Galietta LJ, and Verkman AS. Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J Clin Invest 115: 2564-2571, 2005.
19. Perez A, Davis PB. Gene profile after Pseudomonas aeruginosa exposure in cystic fibrosis tracheal epithelial cells vs. normal tracheal cells. J Struct Funct Genomics 5: 179-194, 2004.
20. - secretion in 9/HTEo- cells in culture. Am J Physiol Lung Cell Mol Physiol 271: L85-L92, 1996.
21. Rajan S, Cacalano G, Bryan R, Ratner AJ, Sontich CU, van Heeckeren A, Davis PB, Prince A. Pseudomonas aeruginosa induction of apoptosis in respiratory epithelial cells: analysis of the effects of cystic fibrosis transmembrane conductance regulator dysfunction and bacterial virulence factors. Am J Respir Cell Mol Biol 23: 304-312, 2000.
22. Salinas D, Haggie PM, Thiagarajah JR, Song Y, Rosbe K, Finkbeiner WE, Nielson DW, Verkman AS. Submucosal gland dysfunction as a primary defect in cystic fibrosis. FASEB J 19: 431-433, 2005.
23. Sims DE, Horne MM. Heterogeneity of the composition and thickness of tracheal mucus in rats. Am J Physiol Lung Cell Mol Physiol 273: L1036-L1041, 1997.
24. Smith JJ, Travis SM, Greenberg EP, Welsh MJ. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85: 229-236, 1996.
25. Sonawane ND, Muanprasat C, Nagatani R Jr, Song Y, Verkman AS. In vivo pharmacology and antidiarrheal efficacy of a thiazolidinone CFTR inhibitor in rodents. J Pharm Sci 94: 134-143, 2005.
26. Stutts MJ, Canessa CM, Olsen JC, Hamrick M, Cohn JA, Rossier BC, Boucher RC. CFTR as a cAMP-dependent regulator of sodium channels. Science 269: 847-850, 1995.
27. Taddei A, Folli C, Zegarra-Moran O, Fanen P, Verkman AS, Galietta LJV. Altered channel gating mechanism for CFTR inhibition by a high-affinity thiazolidinone blocker. FEBS Lett 558: 52-56, 2004.
28. Thiagarajah JR, Song Y, Haggie PM, Verkman AS. A small molecule CFTR inhibitor produces cystic fibrosis-like submucosal gland fluid secretions in normal airways. FASEB J 18: 875-877, 2004.
29. + absorption in collecting duct principal cells isolated from BPK ARPKD mice. Am J Physiol Renal Physiol 286: F244-F254, 2004.
30. Zabner J, Smith JJ, Karp PH, Widdicombe JH, Welsh MJ. Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro. Mol Cell 2: 397-403, 1998.